The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

Market Cap	10.81B
Revenue (ttm)	10.87B
Net Income (ttm)	689.80M
Shares Out	31.24M
EPS (ttm)	22.08
PE Ratio	15.67
Forward PE	14.18
Dividend	6.00 (1.73%)
Ex-Dividend Date	n/a

Volume	353,411
Open	n/a
Previous Close	338.40
Day's Range	338.00 - 354.00
52-Week Range	223.50 - 369.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,000
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2023, IBNSINA's revenue was 9.13 billion, an increase of 7.61% compared to the previous year's 8.48 billion. Earnings were 605.42 million, a decrease of -0.07%.